3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
68
Lung Neoplasms
12
Adenocarcinoma
3
Pancreatic Neoplasms
2
Non-small-cell Lung Cancer With Somatic EGFR Mutations
2
Neoplasms
2
NSCLC
2
Melanoma
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Small Cell Lung Carcinoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Pleural Diseases
1
Ovarian Neoplasms
1
Neoplasms by Site
1
NSCLC Harboring NRG1 Fusion
1
Interventions
pembrolizumab
3
Taxes
2
Polymerase Chain Reaction
2
Nivolumab
2
Nicotine
2
Immunohistochemistry
2
Gene Expression Profiling
2
Fluorodeoxyglucose F18
2
Counseling
2
Bupropion
2
trastuzumab deruxtecan
1
motexafin gadolinium
1
mogamulizumab
1
fluoromisonidazole
1
brodalumab
1
belinostat
1
Zinc Oxide
1
Varenicline
1
Tobacco Use Cessation Devices
1
Rubidium-82
1
Ritonavir
1
Referral and Consultation
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Pemetrexed
1
Paclitaxel
1
Nicotine Replacement Therapy
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Indinavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Afatinib
×
Thoracic
×
Clear all
NCT06897735
2026-06-03
EDDIS-a1
Petrov, Andrey
Phase 1
Terminated
4 enrolled